Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Interferon-α-2b/peginterferon-α-2b/ribavirin

Breakthrough viraemia: case report

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Kawaoka T, Hiraga N, Takahashi S, Takaki S, Tsuge M, Nagaoki Y, Hashimoto Y, Katamura Y, Miki D, Hiramatsu A, Waki K, Imamura M, Kawakami Y, Aikata H, Ochi H, Tashiro H, Ohdan H, Chayama K.Achievement of sustained viral response after switching treatment from pegylated interferon alpha-2b to alpha-2a and ribavirin in patients with recurrence of hepatitis C virus genotype 1 infection after liver transplantation: A case report. Intervirology 55: 306-310, No. 4, Apr 2012. Available from: URL: http://dx.doi.org/10.1159/000328661 - Japan

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Interferon-α-2b/peginterferon-α-2b/ribavirin. React. Wkly. 1414, 31 (2012). https://doi.org/10.2165/00128415-201214140-00101

    Download citation

    Keywords

    • Hepatocellular Carcinoma
    • Liver Cirrhosis
    • Interferon Therapy
    • Undergo Liver Transplantation
    • Sustained Viral Response